LARREGOLA ET AL.
discussions. We also thank Vanessa Point for her assistance in
peptide syntheses.
20 Freidinger RM. Design and synthesis of novel bioactive peptides and
peptidomimetics. J. Med. Chem. 2003; 46: 5553–5566.
21 Patel YC, Wheatley T. In vivo and in vitro plasma disappearance and
metabolism of somatostatin-28 and somatostatin-14 in the rat.
Endocrinology 1983; 112: 220–225.
22 Etzkorn FA, Guo T, Lipton MA, Goldberg SD, Bartlett PA. Cyclic
hexapeptides and chimeric peptides as mimics of tendamistat.
J. Am. Chem. Soc. 1994; 116: 10412–10425.
Supporting information
Supporting information may be found in the online version of this
article.
23 Matter H, Kessler H. Structures, dynamics, and biological activities of
15cyclichexapeptideanalogsoftheα-amylaseinhibitortendamistat
(HOE 467) in solution. J. Am. Chem. Soc. 1995; 117: 3347–3359.
24 Sefler AM, Kozlowski MC, Guo T, Bartlett PA. Design, synthesis, and
evaluation of a depsipeptide mimic of tendamistat. J. Org. Chem.
1997; 62: 93–102.
25 Ono S, Hirano T, Yasutake H, Matsumoto T, Yamaura I, Kato T,
Morita H, Fujii T, Yamazaki I, Shimasaki C, Yoshimura T. Biological
and structural properties of cyclic peptides derived from the α-
amylase inhihitor tendamistat. Biosci. Biotechnol. Biochem. 1998; 62:
1621–1623.
26 Seebach D, Dubost E, Mathad RI, Jaun B, Limbach M, Loweneck M,
Flogel O, Gardiner J, Capone S, Beck AK, Widmer H, Langenegger D,
Monna D, Hoyer D. New open-chain and cyclic tetrapeptides,
consisting of α-, β2-, and β3-amino-acid residues, as somatostatin
mimics – a survey. Helvetica Chimica Acta. 2008; 91: 1736–1786.
27 Oh K, Guan Z. A convergent synthesis of new β-turn mimics by click
chemistry. Chem. Commun. 2006; 29: 3069–3071.
References
1 Guharoy M, Chakrabarti P. Secondary structure based analysis and
classification of biological interfaces: identification of binding motifs
in protein-protein interactions. Bioinformatics 2007; 23: 1909–1918.
2 Lins L, Thomas A, Brasseur R. Analysis of accessible surface of
residues in proteins. Protein Sci. 2003; 12: 1406–1417.
3 Rivier J, Brazeau P, Vale W, Ling N, Burgus R, Gilon C, Yardley J,
Guillemin R. Total solid-phase synthesis of tetradecapeptide with
chemical and biological properties of somatostatin. C. R. Acad. Sci.,
´
Serie D 1973; 276: 2737–2740.
4 Brazeau P, Vale W, Burgus R, Ling N, Burtcher M, Rivier J, Guillemin R.
Hypothalamic polypeptide that inhibits the secretion of
immunoreactive pituitary growth hormone. Science 1973; 179:
77–79.
5 Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S. Cloning and
functional characterization of a family of human and mouse
somatostatin receptors expressed in brain, gastrointestinal-tract,
and kidney. Proc. Natl. Acad. Sci., USA 1992; 89: 251–255.
6 Patel YC. Somatostatin and its receptorfamily. FrontNeuroendocrinol
1999; 20: 157–198.
7 Hofland LJ, Lamberts SWJ. The pathophysiological consequences of
somatostatin receptor internalization and resistance. Endocr. Rev.
2003; 24: 28–47.
8 Vertesy L, Oeding V, Bender R, Zepf K, Nesemann G. Tendamistat
(Hoe 467), a tight-binding α-amylase inhibitor from Streptomyces-
tendae 4158 – isolation, biochemical-properties. Eur. J. Biochem.
1984; 141: 505–512.
9 Pflugrath JW, Wiegand G, Huber R, Vertesy L. Crystal-structure
determination, refinement and the molecular-model of the α-
amylase inhibitor Hoe-467a. J. Mol. Biol. 1986; 189: 383–386.
10 Wiegand G, Epp O, Huber R. The crystal structure of porcine
pancreatic α-amylase in complex with the microbial inhibitor
tendamistat. J. Mol. Biol. 1995; 247: 99–110.
11 Pepermans H, Tourwe D, Vanbinst G, Boelens R, Scheek RM,
Vangunsteren WF. The combined use of NMR, distance geometry,
and restrained molecular-dynamics for the conformational study of
a cyclic somatostatin analog. Biopolymers 1988; 27: 323–338.
12 He YB, Huang ZW, Raynor K, Reisine T, Goodman M. Syntheses
and conformations of somatostatin-related cyclic hexapeptides
incorporating specific α-methylated and β-methylated residues.
J. Am. Chem. Soc. 1993; 115: 8066–8072.
13 Melacini G, Zhu Q, Osapay G, Goodman M. A refined model for
the somatostatin pharmacophore: conformational analysis of
lanthionine-sandostatinanalogs.J.Med.Chem.1997;40:2252–2258.
14 MacDonald M, Aube J. Approaches to cyclic peptide β-turn mimics.
Curr. Org. Chem. 2001; 5: 417–438.
15 Burgess K. Solid-phase syntheses of β-turn analogues to mimic
or disrupt protein-protein interactions. Acc. Chem. Res. 2001; 34:
826–835.
28 Meldal M, Tornøe CW. Cu-catalyzed azide-alkyne cycloaddition.
Chem. Rev. 2008; 108: 2952–3015.
29 Beierle JM, Horne WS, Van Maarseveen JH, Waser B, Reubi JC,
Ghadiri MR.Conformationallyhomogeneousheterocyclicpseudote-
trapeptides as three-dimensional scaffolds for rational drug design:
receptor-selective somatostatin analogues. Angew. Chem. Int. Ed.
2009; 48: 4725–4729.
30 Quancard J, Karoyan P, Lequin O, Wenger E, Aubry A, Lavielle S,
Chassaing G. Prolinoamino acids as tool to stabilize β-turns with
the side chain of natural amino acids. Tetrahedron Lett. 2004; 45:
623–625.
31 Mothes C∗, Larregola M∗, Quancard J, Goasdoue´ N, Lavielle S,
Chassaing G, Lequin O, Karoyan P. Prolinoamino acids as tools to
build bifunctionalized stable β-turns in water. ChemBioChem 2010;
11: 55–58.
32 Lundquist JT, Pelletier JC. Improved solid-phase peptide synthesis
method utilizing α-azide-protected amino acids. Org. Lett. 2001; 3:
781–783.
33 Yuan CG,Williams RM.Totalsynthesisoftheantimethicillin-resistant
StaphylococcusaureuspeptideantibioticsTAN-1057A-D.J.Am.Chem.
Soc. 1997; 119: 11777–11784.
34 Moumne R, Larregola M, Boutadla Y, Lavielle S, Karoyan P.
Aminomethylation of chiral silyl enol ethers : acces to β2-
homotryptophan and β2-homolysine derivatives. Tetrahedron Lett.
2008; 49: 4704–4707.
35 Bartels C, Xia T, Billeter M, Gu¨ntert P, Wu¨thrich K. The program
XEASY for computer-supported NMR spectral analysis of biological
macromolecules. J. Biomol. NMR 1995; 6: 1–10.
36 Szyperski T, Gu¨ntert P, Otting G, Wu¨thrich K. Determination of scalar
coupling-constants by inverse Fourier transformation of in-phase
multiplets. J. Mag. Res. 1992; 99: 552–560.
37 Wishart DS, Bigam CG, Holm A, Hodges RS, Sykes BD. H-1, C-13 and
N-15 random coil NMR chemical-shifts of the common amino-acids.
1. Investigations of nearest-neighbor effects. J. Biomol. NMR. 1995; 5:
67–81.
38 Cline DJ, Thorpe C, Schneider JP. General method for facile
intramolecular disulfide formation in synthetic peptides. Anal.
Biochem. 2004; 335: 168–170.
39 Tornøe CW, Christensen C, Morten Meldal M. Peptidotriazoles on
solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-
dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem.
2002; 67: 3057–3064.
16 Kee S, Jois SDS. Design of β-turn based therapeutic agents. Current
Pharm. Design. 2003; 9: 1209–1224.
17 De Vega MJP, Martin-Martinez M, Gonzalez-Muniz R. Modulation
of protein-protein interactions by stabilizing/mimicking protein
secondary structure elements. Current Topics Med. Chem. 2007; 7:
33–62.
18 Veber DF, Freidinger RM, Schwenk Perlow D, Paleveda WJ, Jr.
Holly FW, Strachan RG, Nutt RF, Arison BH, Homnick C, Randall WC,
Glitzer MS, Saperstein R, Hirschmann R. A potent cyclic hexapeptide
analogue of somatostatin. Nature 1981; 292: 55–58.
19 Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P,
Petcher TJ, Pless J. Sms 201-995 – a very potent and selective
octapeptide analog of somatostatin with prolonged action. Life
Sci. 1982; 31: 1133–1140.
40 Rostovtsev VV,Green LG,Fokin VV,Sharpless KB.AstepwiseHuisgen
cycloaddition process: copper(I)-catalyzed regioselective ligation
of azides and terminal alkynes. Angew. Chem. Int. Ed. 2002; 41:
2596–2599.
41 Kolb HC, Finn MG, Sharpless KB. Click chemistry: diverse chemical
function from a few good reactions. Angew. Chem. Int. Ed. 2001; 40:
2004–2021.
c
wileyonlinelibrary.com/journal/jpepsci Copyright ꢀ 2011 European Peptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. 2011; 17: 632–643